Your browser doesn't support javascript.
loading
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Anstee, Quentin M; Lucas, Kathryn J; Francque, Sven; Abdelmalek, Manal F; Sanyal, Arun J; Ratziu, Vlad; Gadano, Adrian C; Rinella, Mary; Charlton, Michael; Loomba, Rohit; Mena, Edward; Schattenberg, Jörn M; Noureddin, Mazen; Lazas, Donald; Goh, George B B; Sarin, Shiv K; Yilmaz, Yusuf; Martic, Miljen; Stringer, Rowan; Kochuparampil, Jossy; Chen, Li; Rodriguez-Araujo, Gerardo; Chng, Elaine; Naoumov, Nikolai V; Brass, Clifford; Pedrosa, Marcos C.
Afiliação
  • Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Lucas KJ; Diabetes and Endocrinology Consultants, Morehead City, North Carolina, USA.
  • Francque S; Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium.
  • Abdelmalek MF; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Sanyal AJ; European Reference Network on Hepatological Diseases (ERN RARE-LIVER).
  • Ratziu V; Mayo Clinic, Rochester, Minnesota, USA.
  • Gadano AC; Virginia Commonwealth University, Richmond, Virginia, USA.
  • Rinella M; Sorbonne Université, Hôpital Pitié Salpêtrière, ICAN Paris, France.
  • Charlton M; Liver Unit, Hospital Italiano de Buenos Aires, Argentina.
  • Loomba R; University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
  • Mena E; University of Chicago, Chicago, Illinois, USA.
  • Schattenberg JM; University of California at San Diego, La Jolla, California, USA.
  • Noureddin M; California Liver Research Institute, Pasadena, California, USA.
  • Lazas D; Metabolic Liver Research Program, I. Department of Medicine, University Medical Center Mainz, Germany.
  • Goh GBB; Houston Research Institute, Houston, Texas, USA.
  • Sarin SK; Digestive Health Research and ObjectiveHealth, Nashville, Tennessee, USA.
  • Yilmaz Y; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
  • Martic M; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Stringer R; Department of Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.
  • Kochuparampil J; Department of Gastroenterology, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
  • Chen L; Novartis Pharma AG, Basel, Switzerland.
  • Rodriguez-Araujo G; Novartis Pharma AG, Basel, Switzerland.
  • Chng E; Novartis Pharma AG, Basel, Switzerland.
  • Naoumov NV; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Brass C; AbbVie, California, USA.
  • Pedrosa MC; HistoIndex Pte. Ltd, Singapore.
Hepatology ; 78(4): 1223-1239, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37162151
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos